−12.56 BKRW
13.85 MKRW
7.28 M
About NMP
Sector
Headquarters
Seoul
Employees (FY)
19
Website
Founded
2010
ISIN
KR7229500004
FIGI
BBG00B9KQV77
NovMetaPharma Co., Ltd. engages in the manufacture and sale of biological drugs for insulin resistance and related metabolic diseases. Its business areas include new medicine development and healthy foods. Its products include medicines for diabetes, obesity, Alzheimer's disease, immunity cure, osteoporosis, and non-alcoholic fatty liver. The company was founded on November 4, 2010 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 229500 is 20 500 KRW — it has increased by 2.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NMP stocks are traded under the ticker 229500.
Yes, you can track NMP financials in yearly and quarterly reports right on TradingView.
Like other stocks, 229500 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NMP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 19.00 employees. See our rating of the largest employees — is NMP on this list?